Articles tagged "Kidney transplantation"

2021 American Transplant Congress
Kidney Transplant Outcomes in HIV+ Recipients: A Single-Center Study
M. Samra¹, A. Hall², I. Tang²
¹Medicine, Edward Hines VA, Hines, IL, ²Medicine, University of Illinois, Chicago, IL
*Purpose: HIV+ patients are eligible to recieve a kidney transplant (KT) provided they meet criteria of undetectable viral load (VL) and CD4 count >200. We…
2021 American Transplant Congress
Impact of Belatacept and Tacrolimus on Cmv Viral Load Control and Relapse in Moderate and High-risk Cmv Serostatus Kidney Transplant Recipients
W. Magua¹, A. C. Johnson¹, G. M. Karadkhele¹, I. R. Badell¹, P. Vasanth¹, M. G. Lyon III², A. K. Mehta², K. A. Easley³, J. Rickert⁴, C. P. Larsen¹
¹Department of Surgery, Emory University, Atlanta, GA, ²Department of Medicine, Emory University, Atlanta, GA, ³Biostatistics and Bioinformatics, Emory University, Atlanta, GA, ⁴RStudio and R Consortium, San Jose, CA
*Purpose: We aim to evaluate the impact of belatacept and tacrolimus on CMV viral load control, remission and relapse in CMV high-risk (serostatus, D+/R-) and…
2021 American Transplant Congress
Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single Center Experience
M. Carter¹, M. Fitzmaurice², S. Yeddula², A. Singh², S. Nagai², S. Jafri²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Health System, Detroit, MI
*Purpose: Transplant-related Hepatitis E virus (HEV) infection is a rarely recognized entity with significant clinical importance given potential for chronic hepatitis post-transplant. We evaluated HEV…
2021 American Transplant Congress
Findings from the BARETO Study: A New, Composite Renal Vascular Plaque Score is Highly Associated with Kidney Graft Survival
J. Foutz¹, D. Stewart¹, L. Kamal², H. McGehee¹, P. Saravanane², S. Yu², R. Yousfi², G. Gupta²
¹United Network for Organ Sharing, Richmond, VA, ²Virginia Commonwealth University School of Medicine, Richmond, VA
*Purpose: Whether anatomic findings such as aortic and arterial renal plaque affect kidney graft outcomes is not well defined. Other than anatomical damage, it is…
2021 American Transplant Congress
Can Procurement Biopsy Data Tell Us Anything? The Influence of Interstitial Fibrosis on Long-term Kidney Graft Survival
D. Stewart¹, J. Foutz¹, L. Kamal², H. McGehee¹, P. Saravanane², S. Yu³, R. Yousfi², G. Gupta²
¹Research, United Network for Organ Sharing, Richmond, VA, ²Virginia Commonwealth University Health, Richmond, VA, ³Research, Virginia Commonwealth University Health, Richmond, VA
*Purpose: Biopsy findings have been shown to have a profound impact on kidney utilization decisions. Most studies of the association between procurement biopsy findings and…
2021 American Transplant Congress
How Should Acute T-Cell Mediated Rejection of Kidney Transplants be Treated?
F. Aziz¹, S. Parajuli², N. Garg², M. Mohamed², A. Djamali², D. Mandelbrot²
¹University of Wisconsin, Madison, WI, ²University of Wisconsin, Verona, WI
*Purpose: Many guidelines suggest treating acute T-cell mediated rejection (TCMR) of kidney allografts that is Banff grade I with steroids alone and Banff grade II…
2021 American Transplant Congress
Safety and Tolerability of Tacrolimus Extended-Release (astagraf Xl) in Hla Sensitized Kidney Transplant Recipients: A Single Center Experience
A. A. Vo, N. Ammerman, E. Huang, A. Peng, R. Najjar, S. Sethi, K. Lim, M. Gillespie, S. C. Jordan
Cedars Sinai Medical Ctr, Los Angeles, CA
*Purpose: Pill burden is a limitation in kidney transplant. Tacrolimus extended-release (Astagraf XL) is a once daily formulation approved for kidney transplantation. Increased compliance could…
2021 American Transplant Congress
Tolerability of Mycophenolate Mofetil in Elderly Kidney Transplant Recipients: A Retrospective Cohort Study
S. Witek¹, G. Malat², D. Sawinski², C. Sammons², C. LaFratte¹, A. Forte¹, R. Samudralwar¹, S. Lyle¹, J. Rashid¹, J. Trofe-Clark²
¹Dept of Pharmacy, Hospital of the Univ of Pennsylvania, Philadelphia, PA, ²Penn Transplant Institute, Hospital of the Univ of Pennsylvania, Philadelphia, PA
*Purpose: Optimal immunosuppression in elderly kidney transplant recipients (KTRs) is not well-defined, with MMF being poorly tolerated at standard doses. This study aims to compare…
2021 American Transplant Congress
Identifying Health-System Level Barriers and Facilitators to Living Donor Kidney Transplantation: A Comparative Case Study
A. Horton¹, M. Fortin², P. Nugus³, D. Landsberg⁴, M. Paquet², M. Cantarovich¹, S. Sandal¹
¹Nephrology, McGill University Health Centre, Montreal, QC, Canada, ²Nephrology, Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada, ³Family Medicine, McGill University, Montreal, QC, Canada, ⁴Nephrology, University of British Columbia, Vancouver, BC, Canada
*Purpose: Despite the well-known advantages of living donor kidney transplantation (LDKT), rates at many centers have stagnated or declined. In Canada, there are large interprovincial…
2021 American Transplant Congress
Early Experience with Broad Renal Genetic Testing in an Academic Transplant Center
E. Tantisattamo¹, K. Brossart², N. Ioannou², S. McCormick², P. R. Billings², H. Tabriziani²
¹Division of Nephrology, Hypertension and Kidney Transplantation, Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine, Orange, CA, ²Natera, Inc., San Carlos, CA
*Purpose: Genetic testing is an emerging tool in kidney transplantation (KT), particularly to assess risk of recurrent disease in patients with KT and for selection…